Swiss National Bank »

Enliven Therapeutics shares owned by Swiss National Bank

Quarter-by-quarter ownership of Enliven Therapeutics (ELVN) shares owned by Swiss National Bank from 13F filings

Historical chart of Swiss National Bank investment in Enliven Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Enliven Therapeutics held by Swiss National Bank consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Enliven Therapeutics by Swiss National Bank

Quarter filed Position value Share count Share price at filing
2024-03-31 $647k 37k 17.59
2023-12-31 $505k 37k 13.84
2023-09-30 $556k 41k 13.66
2023-06-30 $1.0M 49k 20.41